E3 PreliminaryPreliminaryPEM not requiredCase-ControlPeer-reviewedMachine draft
Resting muscle pain as the first clinical symptom in children carrying the MTTK A8344G mutation.
van de Glind, Gretha, de Vries, Maaike, Rodenburg, Richard et al. · European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society · 2007 · DOI
Quick Summary
This study describes children in a family who carried a specific genetic mutation in their mitochondria (the energy-producing parts of cells) and presented with muscle pain as their first symptom. The researchers found that muscle pain combined with fatigue in children can sometimes be mistakenly labeled as fibromyalgia or chronic fatigue syndrome, when the real cause is actually a rare inherited mitochondrial disorder called MERRF syndrome.
Why It Matters
This study is important because it demonstrates that some cases of pediatric fatigue and muscle pain labeled as ME/CFS or fibromyalgia may actually be due to underlying genetic mitochondrial disorders. Understanding this distinction could improve diagnostic accuracy and enable appropriate genetic testing and family screening for affected individuals.
Observed Findings
- Children in the family presented with recurrent resting muscle pain as the first symptom of disease
- Fatigue was common in pubertal-age children and often co-occurred with muscle pain
- In the absence of obvious biochemical/metabolic abnormalities and neurological symptoms, diagnoses of fibromyalgia or chronic fatigue syndrome were frequently assigned
- Variableheterop lasmy levels of the MTTK A8344G mutation were observed across family members
Inferred Conclusions
- Mitochondrial disorders should be considered in the differential diagnosis of pediatric fatigue and muscle pain, particularly when other causes are not evident
- Recurrent muscle pain combined with fatigue in children warrants investigation for hereditary metabolic and mitochondrial disorders before assigning psychiatric or functional diagnoses
- Genetic testing may be warranted in families presenting with this symptom constellation to identify underlying mitochondrial mutations
Remaining Questions
- How common is the MTTK A8344G mutation in broader ME/CFS patient populations?
- What phenotypic factors predict which patients with muscle pain and fatigue will have detectable mitochondrial mutations?
- How does heteroplasmy level correlate with symptom severity and age of onset in affected families?
What This Study Does Not Prove
This study does not prove that all ME/CFS cases are caused by MTTK mutations, nor does it establish the prevalence of mitochondrial mutations in ME/CFS populations. Being a case report from a single family, it cannot establish causation or generalizability to broader ME/CFS cohorts.
Tags
Symptom:PainFatigue
Biomarker:Gene Expression
Phenotype:Gradual OnsetPediatric
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →